Free Trial
OTCMKTS:REMI

Remedent (REMI) Stock Price, News & Analysis

Remedent logo
$0.01 0.00 (0.00%)
As of 07/11/2025

About Remedent Stock (OTCMKTS:REMI)

Key Stats

Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.02
52-Week Range
$0.01
$0.07
Volume
N/A
Average Volume
5,080 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive REMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter.

REMI Stock News Headlines

Financial Analysis: Remedent (REMI) vs. Its Peers
Remedent (REMI) and Its Peers Head to Head Analysis
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
REMYY Rémy Cointreau SA
Peterson Remy
See More Headlines

REMI Stock Analysis - Frequently Asked Questions

Remedent's stock was trading at $0.0550 at the start of the year. Since then, REMI shares have decreased by 81.8% and is now trading at $0.01.

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS (MKSI) and M&T Bank (MTB).

Company Calendar

Today
7/14/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:REMI
CIK
1078037
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$990 thousand
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-0.19

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:REMI) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners